Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer

This publication has 60 references indexed in Scilit:

• Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma
  British Journal of Surgery, 2001
• The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines
  International Journal of Cancer, 2001
• CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma
  Cancer, 2000
• Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma
  British Journal of Surgery, 1998
• Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma
  Cancer, 1995
• Identification and Screening of 416 Patients with Chronic Hepatitis at High Risk to Develop Hepatocellular Cancer
  Annals of Surgery, 1995
• Clinical Usefulness of CYFRA Assay in Diagnosing Lung Cancer: Measurement of Serum Cytokeratin Fragment
  Japanese Journal of Cancer Research, 1994
• Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma
  Hepatology, 1994
• CYFRA 21-1: A new marker in lung cancer
  Cancer, 1993
• Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections
  The Journal of Pathology, 1988